Erin M. Wessling - 02 Sep 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Chief Legal Officer
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 02 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Sep 2025, 11:53:47 UTC
Previous filing: 05 Sep 2025
Next filing: 05 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wessling Erin M	EVP & Chief Legal Officer	220 VIRGINIA AVENUE, INDIANAPOLIS	/s/ Kathleen S. Kiefer, Attorney in fact	04 Sep 2025	0002084548

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Award	$0	+931	+22%	$0.000000	5,172	02 Sep 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+3,541		$0.000000	3,541	02 Sep 2025	Common Stock	3,541	$322.33	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units. Restrictions lapse as follows: 310 shares each on 9/2/2026 and 9/2/2027, and 311 on 9/2/2028.
F2	The option represents a right to purchase a total of 3,541 shares, and is exercisable in three annual installments, with two installments of 1,180 shares each and one installment of 1,181 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date.